|
Montenegro MF, Marti-Diaz R, Navarro A, Tolivia J, Sanchez-Del-Campo L, Cabezas-Herrera J, Rodriguez-Lopez JN. Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy. Cell Death Dis. 2023 Nov 23;14(11):761. doi: 10.1038/s41419-023-06288-9. PubMed PMID: 37996408; PubMed Central PMCID: PMC10667277.
AÑO: 2023; IF: 8.1
|
37996408
|
Bastonini E, Kovacs D, Lotti F, Sanchez-Del-Campo L. Editorial: Cell stress responses and metabolic reprogramming in skin diseases. Front Cell Dev Biol. 2023 Mar 1;11:1171812. doi: 10.3389/fcell.2023.1171812. eCollection 2023. No abstract available. PubMed PMID: 36936680; PubMed Central PMCID: PMC10014911.
AÑO: 2023; IF: 4.6
|
|
Sanchez-Del-Campo L, Marti-Diaz R, Montenegro MF, Gonzalez-Guerrero R, Hernandez-Caselles T, Martinez-Barba E, Pinero-Madrona A, Cabezas-Herrera J, Goding CR, Rodriguez-Lopez JN. MITF induces escape from innate immunity in melanoma. J Exp Clin Cancer Res. 2021 Mar 31;40(1):117. doi: 10.1186/s13046-021-01916-8. PubMed PMID: 33789714; PubMed Central PMCID: PMC8015040.
AÑO: 2021; IF: 12.658
|
|
Hamm M, Sohier P, Petit V, Raymond JH, Delmas V, Le Coz M, Gesbert F, Kenny C, Aktary Z, Pouteaux M, Rambow F, Sarasin A, Charoenchon N, Bellacosa A, Sanchez-Del-Campo L, Mosteo L, Lauss M, Meijer D, Steingrimsson E, Jonsson GB, Cornell RA, Davidson I, Goding CR, Larue L. BRN2 is a non-canonical melanoma tumor-suppressor. Nat Commun. 2021 Jun 17;12(1):3707. doi: 10.1038/s41467-021-23973-5. PubMed PMID: 34140478; PubMed Central PMCID: PMC8211827.
AÑO: 2021; IF: 16.6
|
|
Montenegro MF, Gonzalez-Guerrero R, Sanchez-Del-Campo L, Pinero-Madrona A, Cabezas-Herrera J, Rodriguez-Lopez JN. PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation. Sci Rep. 2020 Aug 6;10(1):13275. doi: 10.1038/s41598-020-70289-3. PubMed PMID: 32764667; PubMed Central PMCID: PMC7413540.
AÑO: 2020; IF: 4.379
|